TrialJournal for immunotherapy of cancer2023

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.

Rasmus Erik Johansson Mortensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.